23 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30336197 | Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells. | 2019 Jan | 1 |
2 | 31044552 | IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-κB signaling pathway to increase of major vault protein. | 2019 Jul | 3 |
3 | 29257330 | Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. | 2018 Mar | 2 |
4 | 30288106 | S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism. | 2018 | 1 |
5 | 28597042 | Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. | 2017 Aug | 2 |
6 | 27330316 | Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression. | 2016 | 4 |
7 | 26710702 | [Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin]. | 2015 Jun 23 | 1 |
8 | 21793937 | The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. | 2012 Feb | 1 |
9 | 22989452 | [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP]. | 2012 Sep | 3 |
10 | 19875192 | Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. | 2010 Jul | 1 |
11 | 19900859 | Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival. | 2009 Nov | 1 |
12 | 16364413 | Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells. | 2006 Jul | 5 |
13 | 16465425 | Direct activation of the human major vault protein gene by DNA-damaging agents. | 2006 Mar | 2 |
14 | 15547764 | Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines. | 2004 Dec | 9 |
15 | 12520742 | [Expression of lung resistant-related protein in ovarian cancer and its clinical significance]. | 2002 Dec | 4 |
16 | 11745417 | Overexpression of the human major vault protein in astrocytic brain tumor cells. | 2001 Nov 1 | 1 |
17 | 11004683 | Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. | 2000 Oct 15 | 1 |
18 | 11372415 | [Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins]. | 2000 Oct | 1 |
19 | 9667676 | A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer. | 1998 Jun | 2 |
20 | 9713513 | Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. | 1998 Jul-Aug | 2 |
21 | 9737684 | Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques. | 1998 Sep | 1 |
22 | 9570378 | Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE). | 1997 Nov 11 | 1 |
23 | 3940622 | Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer. | 1986 Jan 1 | 1 |